MedTrace Logo

Magnetic Brain Stimulation in the Treatment of Mild Cognitive Impairment

NCT02420522 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2021-10-08

No results posted yet for this study

Summary

This is a pilot study to test the efficacy of repetitive transcranial magnetic stimulation (rTMS) on cognitive improvement in individuals with mild cognitive impairment (MCI). The main objective of this study is to investigate the ability of rTMS to produce cognitive improvement in individuals with MCI. A secondary objective is to determine whether individuals with MCI following mild brain trauma respond differently to rTMS treatment compared to individuals with non-trauma related MCI.

Participants will undergo both active and sham (placebo) rTMS treatment. Cognitive and psychological assessments will be administered before and after each week of rTMS therapy, for both active and sham conditions. Cognitive testing will include verbal, semantic, logic, visual, conceptual, and memory tasks.

Conditions

Interventions

DEVICE

Repetitive Transcranial Magnetic Stimulation

A non-invasive method of brain stimulation.

DEVICE

Sham Transcranial Magnetic Stimulation

A device designed to look, sound, and feel like a real magnetic stimulation coil without actually stimulating the brain.

Sponsors & Collaborators

  • University of Manitoba

    lead OTHER

Principal Investigators

  • Mandana Modirrousta, MD PhD FRCPC · University of Manitoba

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2017-12-31
Completion
2021-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02420522 on ClinicalTrials.gov